Evidence map›Paper›PMID 39889169›Full record

ArticleMedicine2025

Rare acute generalized exanthematous pustulosis caused by iodixanol: A case report.

Xiuxiu Ma, Chaozhu He, Xiaohong Zeng, Xiaohua He, Yanfang Bi

Abstract readCase Reports
In one paragraph

Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiuxiu MaSchool of Nursing, Nanchang University, First Clinical Medical College, Jiangxi Medical College, Nanchang University, Jiangxi, China.ORCID 0009-0003-0103-6574
Chaozhu HeSchool of Nursing, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Xiaohong ZengSchool of Nursing, Nanchang University, First Clinical Medical College, Jiangxi Medical College, Nanchang University, Jiangxi, China.ORCID 0009-0007-8977-0245
Xiaohua HeSchool of Nursing, Nanchang University, First Clinical Medical College, Jiangxi Medical College, Nanchang University, Jiangxi, China.
Yanfang BiSchool of Nursing, Nanchang University, First Clinical Medical College, Jiangxi Medical College, Nanchang University, Jiangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleAcute generalized exanthematous pustulosis (AGEP) is a rare delayed allergic reaction, which is mostly caused by drugs, but there are few reports of iodixanol in particular. At present, 4 cases induced by iodixanol have been reported in the literature, but none have been reported in China. PATIENT CONCERNS: In this report, we report a case of AGEP induced by intravenous bolus infusion of iodixanol during multislice spiral CT enhanced scanning of the whole abdomen in a patient with rectal malignancy. A 35-year-old female patient presented with a larger rash/erythema on the head and neck and felt itchy. DIAGNOSES: A large erythema/rash and white, sterile pustules based on erythema spread from head, neck to the whole body in a short period of time. Blood cell results showed high levels of white blood cell, neutrophils, C-reactive protein and interleukin-10, and decreased levels of some immune indicators. Pathological biopsy results showed that there was immune cell infiltration around the superficial dermis.

interventionsImmediate avoidance of potential allergens and treatment with steroids, antihistamines and other medications, followed by adjustment with cyclosporine and human immunoglobulin. OUTCOMES: At 1 year's follow-up, the patient did not develop any symptoms of discomfort and increased awareness of allergen prevention. LESSONS: The reported case is an extremely rare and severe AGEP, typically characterized by pruritus, edema, large erythema/rash, dense white needle-like sterile pustules based on erythema/rash, and desquamation. After discontinuation of exposure to iodixanol, the patient received symptomatic supportive treatment, mainly drug response. She eventually recovered without recurrence. In the future, with the in-depth exploration of more studies, the use of Iodine Contrast Media will be more standardized and scientific.

Indexed as

Acute Generalized Exanthematous PustulosisContrast MediaTriiodobenzoic AcidsAdultFemaleHumansContrast MediaiodixanolTriiodobenzoic Acids

Identifiers

PMID39889169
PMCPMC11789881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.